Appili Therapeutics (OTCMKTS:APLIF – Get Rating) and Sigilon Therapeutics (NASDAQ:SGTX – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, analyst recommendations, profitability, institutional ownership and risk. Risk & Volatility Appili Therapeutics has a beta of […]
Sigilon Therapeutics (NASDAQ:SGTX – Get Rating) and Appili Therapeutics (OTCMKTS:APLIF – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability and analyst recommendations. Valuation & Earnings This table compares Sigilon Therapeutics and […]
This agreement is a significant step for Aditxt as it expands its portfolio to include innovative therapies for infectious diseases;
Aditxt will partner with global logistics leader Agility to. | April 20, 2023
17.04.2023 - Aditxt, Inc, (NASDAQ: ADTX) (“Aditxt” or the “Company”), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, is pleased to provide an important update regarding its three innovation . Seite 1